PL374965A1 - Doustna, farmaceutyczna kompozycja zawierająca winorelbinę w miękkich kapsułkach i jej zastosowanie - Google Patents

Doustna, farmaceutyczna kompozycja zawierająca winorelbinę w miękkich kapsułkach i jej zastosowanie

Info

Publication number
PL374965A1
PL374965A1 PL03374965A PL37496503A PL374965A1 PL 374965 A1 PL374965 A1 PL 374965A1 PL 03374965 A PL03374965 A PL 03374965A PL 37496503 A PL37496503 A PL 37496503A PL 374965 A1 PL374965 A1 PL 374965A1
Authority
PL
Poland
Prior art keywords
treatment
pharmaceutical composition
soft capsules
oral pharmaceutical
capsules containing
Prior art date
Application number
PL03374965A
Other languages
English (en)
Other versions
PL206522B1 (pl
Inventor
Joel Bougaret
Elie Leverd
Marie-Madeleine Bohn
Norbert Heintz
Original Assignee
R.P.Scherer Technologies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R.P.Scherer Technologies, Inc. filed Critical R.P.Scherer Technologies, Inc.
Publication of PL374965A1 publication Critical patent/PL374965A1/pl
Publication of PL206522B1 publication Critical patent/PL206522B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL374965A 2002-05-31 2003-05-28 Kompozycja farmaceutyczna zawierająca winorelbinę w miękkich kapsułkach i jej zastosowanie PL206522B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/161,454 US6890558B2 (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment

Publications (2)

Publication Number Publication Date
PL374965A1 true PL374965A1 (pl) 2005-11-14
PL206522B1 PL206522B1 (pl) 2010-08-31

Family

ID=29583441

Family Applications (1)

Application Number Title Priority Date Filing Date
PL374965A PL206522B1 (pl) 2002-05-31 2003-05-28 Kompozycja farmaceutyczna zawierająca winorelbinę w miękkich kapsułkach i jej zastosowanie

Country Status (4)

Country Link
US (2) US6890558B2 (pl)
IL (3) IL162716A0 (pl)
PL (1) PL206522B1 (pl)
ZA (1) ZA200405992B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US20050266031A1 (en) * 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
US7871632B2 (en) * 2004-07-12 2011-01-18 Adventrx Pharmaceuticals, Inc. Compositions for delivering highly water soluble drugs
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) * 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
JP2017526638A (ja) * 2014-06-30 2017-09-14 ミトコンドリアル サブストレート インベンション リミテッドＭｉｔｏｃｈｏｎｄｒｉａｌ Ｓｕｂｓｔｒａｔｅ Ｉｎｖｅｎｔｉｏｎ Ｌｉｍｉｔｅｄ 認知機能向上のための栄養素溶液

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US4307100A (en) 1978-08-24 1981-12-22 Agence Nationale De Valorisation De La Recherche (Anvar) Nor bis-indole compounds usable as medicaments
US4623629A (en) 1983-10-31 1986-11-18 Daniel Kerschensteiner Solid-phase immunoassay support and method of use thereof
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
FR2623089B1 (fr) 1987-11-13 1990-04-27 Pf Medicament Composition pharmaceutique pour l'administration parenterale de navelbine
LU87410A1 (fr) 1988-12-20 1990-07-10 Cird Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
GB9303719D0 (en) 1993-02-24 1993-04-14 Wellcome Found Antiviral therapy
FR2707988B1 (fr) 1993-07-21 1995-10-13 Pf Medicament Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
US5447936A (en) 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US6262093B1 (en) * 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6011041A (en) 1995-07-28 2000-01-04 University Of British Columbia Use of anhydrovinblastine
AU3294097A (en) * 1996-06-03 1998-01-05 Johns Hopkins University School Of Medicine, The Pyridine derivative, composition and method for treating cancer
DE19636889A1 (de) 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
FR2761990B1 (fr) 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
WO2000059473A1 (en) 1999-04-01 2000-10-12 Inex Pharmaceuticals Corp. Compositions and methods for treating lymphoma
DE60007120T2 (de) 1999-05-24 2004-09-16 Southern Research Institute, Birmingham Isophosphoramide-senfgasanalogen und deren verwendung
US6890558B2 (en) * 2002-05-31 2005-05-10 R.P. Scherer Technologies, Inc. Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment

Also Published As

Publication number Publication date
US6890558B2 (en) 2005-05-10
US7658943B2 (en) 2010-02-09
US20030224042A1 (en) 2003-12-04
IL162716A (en) 2015-08-31
ZA200405992B (en) 2005-12-28
IL238491A0 (en) 2015-06-30
IL162716A0 (en) 2005-11-20
US20050163834A1 (en) 2005-07-28
PL206522B1 (pl) 2010-08-31

Similar Documents

Publication Publication Date Title
PL357856A1 (pl) Farmaceutyczne granulki zawierające tamsulozynę oraz sposób ich wytwarzania
EP1615623A4 (en) ORAL SAFETY DOSAGE FORMS AND METHOD OF APPLICATION THEREFOR
IL238491A0 (en) Oral pharmaceutical preparation for soft capsules containing vinorelbine and methods of treatment
IL166108A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
EP1365747A4 (en) PHARMACEUTICAL PRESENTATION OF ORAL PEPTIDE ADMINISTERED AND METHOD OF PRODUCTION
AU2003272450A1 (en) Novel composition and method for treatment of upper respiratory conditions
PL375052A1 (pl) Ochronny pojemnik farmaceutyczny izotopu i sposóbjego zastosowania
IL163693A0 (en) Method and apparatus for replicating the position of intra-osseous implants and abutments relative to analogs thereof
AU2003295634A8 (en) Apparatus and method for palpograhic chacterization of vulnerable plaque and other biological tissue
EP1478345A4 (en) NOVEL PHARMACEUTICAL DOSAGE FORMS AND PROCESS FOR PRODUCTION OF SAID DOSAGE FORMS
EP1567119A4 (en) ORAL HYGIENE SYSTEM AND PROCESSING METHOD THEREOF
AU2003269444A8 (en) An improved pacifier and method of use thereof
IL167907A (en) Bicyclic inhibitors of hormone sensitive lipase, process for their preparation and pharmaceutical compositions comprising them
SG116507A1 (en) Pharmaceutical dosage form and method of making.
IL166054A0 (en) Novel compounds pharmaceutical compositions containing same and methods of use for same
AU2003272081A1 (en) Enteric soft gelatin capsule containing esomeprazole and method of preparation
EP1541474A4 (en) PROCESS FOR STERILIZATION AND DEVICE THEREFOR
AU2003251550A8 (en) Human cystathionine beta-synthase variants and methods of produ ction thereof
AU2003297856A8 (en) Oral compositions and methods for treatment of adverse effects or radiation
AU2003295713A8 (en) Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions
HUP0203676A3 (en) Pharmaceutical composition and method for treatment of diabetes
EP1694242A4 (en) PHARMACEUTICAL PREPARATIONS OF CAMPTOTHECINS AND METHOD FOR OBTAINING THEM
PL365872A1 (pl) Sposób wytwarzania stałej doustnej postaci dawkowania zawierającej metforminę i gliburyd, stała doustna postać dawkowania zawierająca metforminę i gliburyd oraz jej zastosowanie do wytwarzania leku
AU2003291458A8 (en) Pharmaceutical compositions and methods of using taxane derivatives
IL166756A0 (en) A pharmaceutical composition containing a compoundthat reduces activity of MK2 and methods for iden tifying such compounds